J Korean Neurosurg Soc.  2020 Mar;63(2):261-267. 10.3340/jkns.2019.0057.

The Effect of Hypnotics on Sleep Quality and Cognitive Function in Patients with Brain Tumors

• Chang MC
• Chun MH

• KMID: 2501712
• DOI: http://doi.org/10.3340/jkns.2019.0057

Abstract

Objective
: We investigated the effect of hypnotics on sleep quality, cognitive function, and depressive mood in patients with insomnia following brain tumor resection.
Methods
: From patients who underwent brain tumor resection, we recruited 10 patients with insomnia who received hypnotics for more than 1 week during a 3-week follow-up period (insomnia group). We also recruited 12 control patients with brain tumors but without insomnia (control group). We evaluated sleep quality at baseline and 3 weeks later using the Insomnia Severity Index (ISI), the Pittsburgh Sleep Quality Index (PSQI), the Stanford Sleepiness Scale (SSS), and the Epworth Sleepiness Scale (ESS) and investigated cognitive function and depression using the Computerized Neuropsychological Test and the Beck Depression Inventory (BDI).
Results
: At baseline, SSS, ISI, PSQI, and BDI scores were significantly higher and visual continuous performance test (VCPT) and auditory continuous performance test (ACPT) scores were significantly lower in the insomnia than in the control group. Three weeks later, the patients who had received hypnotics had significantly higher ISI, PSQI, ESS, VCPT, ACPT, visual span forward and backward, and visual recognition test scores, and significantly lower BDI scores.
Conclusion
: Quality of sleep in patients with insomnia following brain tumor resection was initially poor but improved significantly after taking hypnotic medication. Further, the hypnotic medications appeared to contribute to the amelioration of cognitive impairments and depressive moods in patients who previously underwent brain tumor resection. We thus recommend the use of hypnotics for patients with brain tumors with insomnia.

Keyword

Hypnotics and sedatives; Sleep initiation and maintenance disorders; Cognition; Depression; Brain neoplasms

Reference

References

1. Alhola P, Polo-Kantola P. Sleep deprivation: impact on cognitive performance. Neuropsychiatr Dis Treat. 3:553–567. 2007.

2. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2:297–307. 2001.

3. Bei B, Asarnow LD, Krystal A, Edinger JD, Buysse DJ, Manber R. Treating insomnia in depression: insomnia related factors predict long-term depression trajectories. J Consult Clin Psychol. 86:282–293. 2018.

4. Berch DB, Krikorian R, Huha EM. The Corsi block-tapping task: methodological and theoretical considerations. Brain Cogn. 38:317–338. 1998.

5. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28:193–213. 1989.

6. Callens CJ, Meltzer ML. Effect of intelligence, anxiety, and diagnosis on arithmetic and digit span performance on the WAIS. J Consult Clin Psychol. 33:630. 1969.

7. Campbell SS, Murphy PJ. The nature of spontaneous sleep across adulthood. J Sleep Res. 16:24–32. 2007.

8. Chervin RD, Aldrich MS, Pickett R, Guilleminault C. Comparison of the results of the Epworth sleepiness scale and the multiple sleep latency test. J Psychosom Res. 42:145–155. 1997.

9. Chua EC, Fang E, Gooley JJ. Effects of total sleep deprivation on divided attention performance. PLoS One. 12:e0187098. 2017.

10. Conners CK, Epstein JN, Angold A, Klaric J. Continuous performance test performance in a normative epidemiological sample. J Abnorm Child Psychol. 31:555–562. 2003.

11. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 262:1479–1484. 1989.

12. Gapstur R, Gross CR, Ness K. Factors associated with sleep-wake disturbances in child and adult survivors of pediatric brain tumors: a review. Oncol Nurs Forum. 36:723–731. 2009.

13. Gu SY, Chang MC. The effects of 10-Hz repetitive transcranial magnetic stimulation on depression in chronic stroke patients. Brain Stimul. 10:270–274. 2017.

14. Ha KS, Kwon JS, Lyoo IK, Kong SW, Lee DW, Youn T. Development and standardization process, and factor analysis of the computerized cognitive function test system for Korea adults. J Korean Neuropsychiatr Assoc. 41:551–562. 2002.

15. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 10:431–436. 1973.

16. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 162:225–233. 2000.

17. Holm KJ, Goa KL. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs. 59:865–889. 2000.

18. Husby R, Lingjaerde O. Prevalence of reported sleeplessness in northern Norway in relation to sex, age and season. Acta Psychiatr Scand. 81:542–547. 1990.

19. Jang SH, Chang MC. Motor outcomes of patients with a complete middle cerebral artery territory infarct. Neural Regen Res. 8:1892–1897. 2013.

20. Mefferd RB Jr, Wieland BA, James WE. Repetitive psychometric measures: digit span. Psychol Rep. 18:3–10. 1966.

21. Milner B. Interhemispheric differences in the localization of psychological processes in man. Br Med Bull. 27:272–277. 1971.

22. Müller HL, Handwerker G, Wollny B, Faldum A, Sörensen N. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab. 87:3993–3996. 2002.

23. Ohayon MM, Hong SC. Prevalence of insomnia and associated factors in South Korea. J Psychosom Res. 53:593–600. 2002.

24. Palomäki H, Berg A, Meririnne E, Kaste M, Lönnqvist R, Lehtihalmes M, et al. Complaints of poststroke insomnia and its treatment with mianserin. Cerebrovasc Dis. 15:56–62. 2003.

25. Pasula EY, Brown GG, McKenna BS, Mellor A, Turner T, Anderson C, et al. Effects of sleep deprivation on component processes of working memory in younger and older adults. Sleep. 41:zsx213. 2018.

26. Provini F, Lombardi C, Lugaresi E. Insomnia in neurological diseases. Semin Neurol. 25:81–89. 2005.

27. Query WT, Megran J. Age-related norms for AVLT in a male patient population. J Clin Psychol. 39:136–138. 1983.

28. Roger M, Attali P, Coquelin JP. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia. Clin Ther. 15:127–136. 1993.

29. Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev. 31:CD006932. 2013.

30. Scharf MB, Mayleben DW, Kaffeman M, Krall R, Ochs R. Dose response effects of zolpidem in normal geriatric subjects. J Clin Psychiatry. 52:77–83. 1991.

31. Schwartz MD, Kilduff TS. The neurobiology of sleep and wakefulness. Psychiatr Clin North Am. 38:615–644. 2015.

32. Taylor DJ. Insomnia and depression. Sleep. 31:447–448. 2008.

33. Zhou ES, Manley PE, Marcus KJ, Recklitis CJ. Medical and psychosocial correlates of insomnia symptoms in adult survivors of pediatric brain tumors. J Pediatr Psychol. 41:623–630. 2016.